Everything from consultations to follow-ups happens through virtual visits
DPP-4 inhibitors showed a significant association with biliary disorders (ROR, 3.09
Acknowledgments This work was supported by the National Key R&D Project of China (2018YFA0704103, 2018YFA0704104) and Fundamental Research Funds for the Central Universities (DUT22YG123, DUT21TD105)
New publication in eClinicalMedicine The Lancet Discovery Science
Chronic Kidney Disease Chronic kidney disease, frequently brought on by longstanding diabetes, can advance to major kidney events, such as end stage renal disease, the need for dialysis, and transplantation each of which can have significant impacts on health and mortality
Top Benefits: Enhances weight loss beyond GLP-1 alone Improves insulin response and glucose stability Boosts overall metabolic performance Once-weekly injectable therapy that mimics the natural GLP-1 hormone to improve appetite control and metabolic efficiency